From: Structuring and validating a cost-effectiveness model of primary asthma prevention amongst children
Inhaled corticosteroid treatment 3 months prior to lung function assessment | Symptom/ Complaint | Reversibility | Hyperreactivity | Asthma |
---|---|---|---|---|
- | + | + | Not Needed | + |
 | + | - | + | + |
 | + | - | - | - |
 | - | + | + | + |
 | - | + | - | - |
 | - | - | Not Needed | - |
+ | Not Needed | + | + | + |
 | Not Needed | + | - | + |
 | Not Needed | - | + | + |
 | Not Needed | - | - | Sensitivity Analysis |